Utility of Tissue Inhibitor Metalloproteinase-1 and Osteopontin as Prospective Biomarkers of Early Cardiovascular Complications in Type 2 Diabetes | Zendy

Doaa Samir Salah El-Din | Zendy; Ahmed Amin | Zendy; Ahmed Osman Egiza | Zendy

Open Access

Utility of Tissue Inhibitor Metalloproteinase-1 and Osteopontin as Prospective Biomarkers of Early Cardiovascular Complications in Type 2 Diabetes

Author(s) -

Doaa Samir Salah El-Din,

Ahmed Amin,

Ahmed Osman Egiza

Publication year - 2018

Publication title -

open access macedonian journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.288

H-Index - 17

ISSN - 1857-9655

DOI - 10.3889/oamjms.2018.081

Subject(s) - medicine , osteopontin , tissue inhibitor of metalloproteinase , diabetes mellitus , metalloproteinase , type 2 diabetes , type 2 diabetes mellitus , endocrinology , gastroenterology , matrix metalloproteinase

This work investigated associations between tissue inhibitor metalloproteinase-1 and diabetic cardiovascular diseases in type 2 diabetic patients; also it investigated the role of osteopontin in the diagnosis of type 2 cardiovascular diabetes complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research